SFS
ACAD icon

Sowell Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Sowell Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,963
Closed -$62K – 532
2021
Q1 		$62K Buy
2,963
+348
+13% +$15.3K ﹤0.01% 1554
2020
Q4 		$140K Buy
2,615
+805
+44% +$40K 0.01% 1010
2020
Q3 		$75K Sell
1,810
-811
-31% -$35K ﹤0.01% 1078
2020
Q2 		$127K Buy
2,621
+867
+49% +$41.6K 0.01% 893
2020
Q1 		$74K Buy
1,754
+258
+17% +$10.6K 0.01% 925
2019
Q4 		$64K Buy
+1,496
New +$65.1K ﹤0.01% 1063

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Sowell Financial Services's ACAD Position: Q2 2021 in Review

Sowell Financial Services sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 2,963 shares — an estimated $62K sold.

Sowell Financial Services first reported a position in ACAD in Q4 2019 and held it in 6 quarters. The position peaked at $140K in Q4 2020. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

  • Sowell Financial Services reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,963 Acadia Pharmaceuticals shares in Q2 2021, an estimated $62K.
  • Sowell Financial Services first reported a position in Acadia Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • Sowell Financial Services's Acadia Pharmaceuticals position peaked at $140K in Q4 2020.
  • 245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.